Oriel Research Therapeutics (ORT) is a bioinformatics company that provides services both for harmonized real-world patients’ derived genomic data, AI based model development, and early detection tests for cancer and other diseases using its AI-based platform.

​

ORT's technology utilizes a state-of-the-art cloud-based software platform, which processes large omic, like gene expressions, and clinical data to build the ORT database. The database is processed with proprietary Artificial Intelligence/Machine Learning (Al/ML) models.

​

The ORT database includes over 1 million RNA-seq profiles from in-vivo and in-vitro patients’ samples with matching clinical data.

​

Oriel Research Therapeutics allows easy access to its large-scale, harmonized, real-world data (RWD) and to its proprietary pipelines to allow a quick adoption of evidence-based hypotheses for diagnosis, therapy matching, and target development.

ORT is a J&J innovation lab company and is located in Cambridge, MA